Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mesothelioma × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Breast Neoplasms 26 Pain, Postoperative 17 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Neoplasms 12 Lung Neoplasms 12 Brain Neoplasms 10 Prostatic Neoplasms 9 Ovarian Neoplasms 8 Colorectal Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Hepatocellular 7 Depression 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Head and Neck Neoplasms 5 Pain 4 Multiple Myeloma 4 Lymphoma 4 Leiomyoma 4 Anxiety Disorders 4 Urinary Bladder Neoplasms 3 Thromboembolism 3 Supratentorial Neoplasms 3 Stomatitis 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Myofibroma 3 Lymphoma, Non-Hodgkin 3

Interventions

Pemetrexed 34 Cisplatin 28 pembrolizumab 19 Nivolumab 15 Carboplatin 15 Ipilimumab 11 Gemcitabine 9 Cyclophosphamide 7 durvalumab 6 fludarabine 5 Bevacizumab 5 Radiotherapy, Intensity-Modulated 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 olaparib 3 niraparib 3 anetumab ravtansine 3 Vinorelbine 3 Paclitaxel 3 LMB-100 3 Imatinib Mesylate 3 Cerebral Decortication 3 sargramostim 2 fludarabine phosphate 2 defactinib 2 budigalimab 2 belinostat 2 atezolizumab 2 Vorinostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05730816 2025-11-21

MAGIC-AKI

Brigham and Women's Hospital

Phase 2 Recruiting

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡